![](/img/cover-not-exists.png)
Does a longer duration of oral factor Xa therapy increase the risk of bleeding or transaminitis?
Aaron M. From, Deana D. Hoganson, Patricia J. ErwinVolume:
127
Year:
2011
Language:
english
DOI:
10.1016/j.thromres.2010.11.017
File:
PDF, 722 KB
english, 2011